Clinical Trial Update: Inhibition of Oral Tumorigenesis by Antitumor B [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating Antitumor B for inhibition of oral tumorigenesis in squamous cell carcinoma of the oral cavity. The trial is completed and results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Antitumor B

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Squamous Cell Cancer of the Oral Cavity | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-03-25